AAAAAA

   
Results: 1-13 |
Results: 13
PHASE-I HIGH-DOSE TRIAL OF I-13 I-LABELED MN-14 F(AB)(2) ANTI-CEA MABCOMBINED WITH AUTOLOGOUS BONE-MARROW SUPPORT IN PATIENTS (PTS) WITH ADVANCED MEDULLARY-THYROID CANCER (MTC)
Authors: JUWEID M SHARKEY RM SWAYNE LC ALEXANDER S DUNN R RUBIN A HERSKOVIC T GOLDENBERG DM
Citation: M. Juweid et al., PHASE-I HIGH-DOSE TRIAL OF I-13 I-LABELED MN-14 F(AB)(2) ANTI-CEA MABCOMBINED WITH AUTOLOGOUS BONE-MARROW SUPPORT IN PATIENTS (PTS) WITH ADVANCED MEDULLARY-THYROID CANCER (MTC), The Journal of nuclear medicine, 38(5), 1997, pp. 168-168
PHASE-I DOSE-ESCALATION TRIAL OF I-131-LABELED MN-14 F(AB)(2) ANTI-CEA MAB IN PATIENTS WITH MEDULLARY-THYROID CANCER (MTC)
Authors: JUWEID M SHARKEY RM SWAYNE LC PETRYK L DUNN R RUBIN A HERSKOVIC T GOLDENBERG DM
Citation: M. Juweid et al., PHASE-I DOSE-ESCALATION TRIAL OF I-131-LABELED MN-14 F(AB)(2) ANTI-CEA MAB IN PATIENTS WITH MEDULLARY-THYROID CANCER (MTC), The Journal of nuclear medicine, 38(5), 1997, pp. 1115-1115
REGRESSION OF ADVANCED REFRACTORY OVARIAN-CANCER TREATED WITH IODINE-131-LABELED ANTI-CEA MONOCLONAL-ANTIBODY
Authors: JUWEID M SHARKEY RM ALAVI A SWAYNE LC HERSKOVIC T HANLEY D RUBIN AD PEREIRA M GOLDENBERG DM
Citation: M. Juweid et al., REGRESSION OF ADVANCED REFRACTORY OVARIAN-CANCER TREATED WITH IODINE-131-LABELED ANTI-CEA MONOCLONAL-ANTIBODY, The Journal of nuclear medicine, 38(2), 1997, pp. 257-260
PROSPECTS OF RADIOIMMUNOTHERAPY IN EPITHELIAL OVARIAN-CANCER - RESULTS WITH IODINE-131-LABELED MURINE AND HUMANIZED MN-14 ANTICARCINOEMBRYONIC ANTIGEN MONOCLONAL-ANTIBODIES
Authors: JUWEID M SWAYNE LC SHARKEY RM DUNN R RUBIN AD HERSKOVIC T GOLDENBERG DM
Citation: M. Juweid et al., PROSPECTS OF RADIOIMMUNOTHERAPY IN EPITHELIAL OVARIAN-CANCER - RESULTS WITH IODINE-131-LABELED MURINE AND HUMANIZED MN-14 ANTICARCINOEMBRYONIC ANTIGEN MONOCLONAL-ANTIBODIES, Gynecologic oncology, 67(3), 1997, pp. 259-271
IMPROVED DETECTION OF MEDULLARY-THYROID CANCER WITH RADIOLABELED ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN
Authors: JUWEID M SHARKEY RM BEHR T SWAYNE LC RUBIN AD HERSKOVIC T HANLEY D MARKOWITZ A DUNN R SIEGEL J KAMAL T GOLDENBERG DM
Citation: M. Juweid et al., IMPROVED DETECTION OF MEDULLARY-THYROID CANCER WITH RADIOLABELED ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN, Journal of clinical oncology, 14(4), 1996, pp. 1209-1217
RADIOIMMUNOTHERAPY OF MEDULLARY-THYROID CANCER WITH IODINE-131-LABELED ANTI-CEA ANTIBODIES
Authors: JUWEID M SHARKEY RM BEHR T SWAYNE LC HERSKOVIC T PEREIRA M RUBIN AD HANLEY D DUNN R SIEGEL J GOLDENBERG DM
Citation: M. Juweid et al., RADIOIMMUNOTHERAPY OF MEDULLARY-THYROID CANCER WITH IODINE-131-LABELED ANTI-CEA ANTIBODIES, The Journal of nuclear medicine, 37(6), 1996, pp. 905-911
IMPROVED DETECTION OF MEDULLARY-THYROID CANCER WITH RADIOLABELED ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN
Authors: JUWEID M SHARKEY RM BEHR TM SWAYNE LC RUBIN AD HERSKOVIC T HANLEY D MARKOWITZ AL DUNN R SIEGEL J KAMAL T GOLDENBERG DM
Citation: M. Juweid et al., IMPROVED DETECTION OF MEDULLARY-THYROID CANCER WITH RADIOLABELED ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN, The Journal of nuclear medicine, 37(5), 1996, pp. 24-24
RADIOIMMUNOTHERAPY OF ADVANCED REFRACTORY OVARIAN-CANCER WITH I-131-LABELED MN-14 IGG ANTI-CEA MAB - AN ONGOING PHASE-I STUDY
Authors: JUWEID M SHARKEY RM BEHR TM SWAYNE LC DUNN R RUBIN A HERSKOVIC T HANLEY D GOLDENBERG DM
Citation: M. Juweid et al., RADIOIMMUNOTHERAPY OF ADVANCED REFRACTORY OVARIAN-CANCER WITH I-131-LABELED MN-14 IGG ANTI-CEA MAB - AN ONGOING PHASE-I STUDY, The Journal of nuclear medicine, 37(5), 1996, pp. 736-736
CLINICAL-EVALUATION OF TUMOR TARGETING WITH THE ANTICARCINOEMBRYONIC ANTIGEN (CEA) MURINE MN-14 F(AB)(2) AS A POTENTIAL AGENT FOR RADIOIMMUNOTHERAPY
Authors: JUWEID M SHARKEY RM BEHR TM MARKOWITZ AL SWAYNE LC DUNN R RUBIN A HERSKOVIC T HANLEY D GOLDENBERG DM
Citation: M. Juweid et al., CLINICAL-EVALUATION OF TUMOR TARGETING WITH THE ANTICARCINOEMBRYONIC ANTIGEN (CEA) MURINE MN-14 F(AB)(2) AS A POTENTIAL AGENT FOR RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 37(5), 1996, pp. 738-738
TC-99M-LL1 - A POTENTIALLY NEW BONE-MARROW IMAGING AGENT
Authors: JUWEID M SHARKEY RM DUNN R HANLEY D HERSKOVIC T RUBIN A HANSEN HJ GOLDENBERG DM
Citation: M. Juweid et al., TC-99M-LL1 - A POTENTIALLY NEW BONE-MARROW IMAGING AGENT, The Journal of nuclear medicine, 37(5), 1996, pp. 1073-1073
TREATMENT OF MEDULLARY-THYROID CANCER (MTC) WITH RADIOLABELED MONOCLONAL-ANTIBODIES (MABS) AGAINST CARCINOEMBRYONIC ANTIGEN (CEA)
Authors: JUWEID M SHARKEY RM BEHR TM SWAYNE LC RUBIN AD HERSKOVIC T HANLEY D GOLDENBERG DM
Citation: M. Juweid et al., TREATMENT OF MEDULLARY-THYROID CANCER (MTC) WITH RADIOLABELED MONOCLONAL-ANTIBODIES (MABS) AGAINST CARCINOEMBRYONIC ANTIGEN (CEA), The Journal of nuclear medicine, 37(5), 1996, pp. 1090-1090
TREATMENT OF NON-HODGKINS-LYMPHOMA WITH RADIOLABELED MURINE, CHIMERIC, OR HUMANIZED LL2, AN ANTI-CD22 MONOCLONAL-ANTIBODY
Authors: JUWEID M SHARKEY RM MARKOWITZ A BEHR T SWAYNE LC DUNN R HANSEN HJ SHEVITZ J LEUNG SO RUBIN AD HERSKOVIC T HANLEY D GOLDENBERG DM
Citation: M. Juweid et al., TREATMENT OF NON-HODGKINS-LYMPHOMA WITH RADIOLABELED MURINE, CHIMERIC, OR HUMANIZED LL2, AN ANTI-CD22 MONOCLONAL-ANTIBODY, Cancer research, 55(23), 1995, pp. 5899-5907
TARGETING AND INITIAL RADIOIMMUNOTHERAPY OF MEDULLARY-THYROID CARCINOMA WITH I-131-LABELED MONOCLONAL-ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN
Authors: JUWEID M SHARKEY RM BEHR T SWAYNE LC RUBIN AD HANLEY D HERSKOVIC T MARKOWITZ A SIEGEL J GOLDENBERG DM
Citation: M. Juweid et al., TARGETING AND INITIAL RADIOIMMUNOTHERAPY OF MEDULLARY-THYROID CARCINOMA WITH I-131-LABELED MONOCLONAL-ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN, Cancer research, 55(23), 1995, pp. 5946-5951
Risultati: 1-13 |